Cosmetics News In Brief: NY Slaps Limit On Cosmetic 1,4-Dioxane Content; J&J Talc Drama; IFF Merger
Executive Summary
Suspected trace carcinogen 1,4-dioxane must be limited to 2 parts per million in personal cleansing products sold in New York after 31 December 2022, and 1 ppm one year later, under recently enacted legislation. More cosmetics news in brief.
You may also be interested in...
Personal-Care Firms Filing Waiver Requests En Masse As 1,4-Dioxane Deadline Looms In New York
More than 800 waivers have been filed by companies including Procter & Gamble, L’Oréal and Coty with the first deadline fast-approaching for limiting 1,4-dioxane in personal-care products under a law enacted in New York in 2019.
DuPont’s Nutrition Business Spin-Off Through Subsidiaries Merger With IFF Moves Toward Closing
IFF announces preliminary results of more than 99% of votes approving issuing shares pursuant to an agreement that positions it as acquiring DuPont Nutrition & Biosciences under a “reverse Morris trust” transaction. The merger is between DuPont Nutrition & Biosciences and a subsidiary IFF established as a corporate entity to conduct the transaction.
Asbestos In Johnson's Baby Powder May Come From Test Labs, J&J Says
No asbestos found in 15 tests from same bottle FDA previously tested and reported finding asbestos. But a contractor's testing processes demonstrated potential for false findings of asbestos.